SECURITIES AND EXCHANGE COMMISSION

 

WASHINGTON, DC  20549

 

FORM 8-K

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

Date of Report (Date of Earliest Event Reported):  March 31, 2003

 

 

DEPOMED, INC.

(Exact name of registrant as specified in its charter)

 

California		001-13111		94-3229046
(State of Incorporation or Organization)		(Commission File Number)		(I.R.S. Employer Identification No.)
1360 O’Brien Drive, Menlo Park, California				94025
(Address of principal executive offices)				(Zip Code)

 

 

 

Registrant’s telephone no., including area code:  (650) 462-5900

 

 

 

NOT APPLICABLE

(Former name or former address, if changed since last report)

 

 

 

Item 7.  Financial Statements and Exhibits

 

Exhibits

99.1

DepoMed, Inc. Press Release issued on March 31, 2003.

 

Item 9.  Regulation FD Disclosure

 

           On March 31, 2003, DepoMed, Inc. issued a press release announcing its financial results for the period ended December 31, 2002.  The press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

 

           The information provided in this Current Report on Form 8-K is being provided under Item 12 of Form 8-K.

 

2

SIGNATURE

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

                                                         DEPOMED, INC.

 

			/s/ John F. Hamilton
			John F. Hamilton
			Vice President - Finance and
			Chief Financial Officer

 

 

 

Date:  April 1, 2003

 

 

3

EXHIBIT INDEX

 

           Exhibit

99.1

DepoMed, Inc. Press Release issued on March 31, 2003.